https://orcid.org/0000-0003-2371-0999
References
- Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221–e1234.
- European glaucoma society terminology and guidelines for glaucoma, 5th edition. Br J Ophthalmol. 2021;105(Suppl 1):769–169.
- Kang JM, Tanna AP. Glaucoma. Med Clin North Am. 2021;105(3):493–510.
- Aref AA, Gedde SJ, Budenz DL. Glaucoma drainage implant surgery. Dev Ophthalmol. 2017;59:43–52.
- Cohen LP, Pasquale LR. Clinical characteristics and current treatment of glaucoma. Cold Spring Harb Perspect Med. 2014;4(6):a017236–a017236.
- Kastner A, King AJ. Advanced glaucoma at diagnosis: current perspectives. Eye. 2020;34(1):116–128.
- Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–2090.
- Real JP, Lafuente MC, Palma SD, et al. Direct costs of glaucoma: relationship between cost and severity of the disease. Chronic Illn. 2020;16(4):266–274.
- Fiscella RG, Lee J, Davis EJ, et al. Cost of illness of glaucoma: a critical and systematic review. Pharmacoeconomics. 2009;27(3):189–198.
- Centers for Disease Control and Prevention (CDC). International classification of diseases, ninth revision, clinical modification (ICD-9-CM). CDC; 2015. [cited 2022 Feb 22]. https://www.cdc.gov/nchs/icd/icd9cm.htm.
- Centers for Disease Control and Prevention (CDC). International classification of diseases, tenth revision, clinical modification (ICD-10-CM). CDC; 2020. [cited 2022 Feb 22]. https://www.cdc.gov/nchs/icd/icd10cm.htm.
- Parliament of Spain. Law 14/2007, 3rd July, on biomedical research (BOE, 4 July 2007). Rev Derecho Genoma Hum. 2007;26:283–325.
- Schuster AK, Erb C, Hoffmann EM, et al. The diagnosis and treatment of glaucoma. Dtsch Arztebl Int. 2020;117(13):225–234.
- Patel HY, Danesh-Meyer HV. Incidence and management of cataract after glaucoma surgery. Curr Opin Ophthalmol. 2013;24(1):15–20.
- Lee PP, Walt JG, Doyle JJ, et al. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol. 2006;124(1):12–19.
- Traverso CE, Walt JG, Kelly SP, et al. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. Br J Ophthalmol. 2005;89(10):1245–1249.
- Tang J, Liang Y, O'Neill C, et al. Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov Model. Lancet Glob Health. 2019;7(7):e968–e978.
- Burr JM, Mowatt G, Hernández R, et al. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess. 2007;11(41):iii–iiv.